A New Indication for Abilify
Recently, the medication Abilify (aripiprazole) was approved by the FDA for the treatment of schizophrenia in the adolescent population aged 13 - 17. This is a significant development in the treatment of schizophrenia, and I thought it would be interesting to explain how this medication received this new indication after being on... Read more




















